日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The ADESTE trial: A phase 2 study of enibarcimab, a monoclonal antibody targeting adrenomedullin, in acute heart failure

ADESTE试验:一项针对急性心力衰竭的单克隆抗体enibarcimab的II期研究,该抗体靶向肾上腺髓质素。

Hartopo, Anggoro Budi; Achyar, Arinal Chairul; Bagaswoto, Hendry Purnasidha; Saputra, Firandi; Mumpuni, Hasanah; Kusumastuti, Dyah Adhi; Triyono, Teguh; Sukorini, Usi; Puspitasari, Metalia; Setianto, Budi Yuli; Rohman, Mohammad Saifur; Anshory, Muhammad; Waranugraha, Yoga; Kamila, Putri Annisa; Iskandar, Agustin; Susianti, Hani; Bergman, Andreas; Knothe, Claudia; Antonini, Paola; Di Somma, Salvatore

Biventricular dysfunction predicts mortality in ST elevation myocardial infarction patients with cardiogenic shock

双心室功能障碍可预测伴有心源性休克的ST段抬高型心肌梗死患者的死亡率

Prasetyo, Angga Dwi; Bagaswoto, Hendry Purnasidha; Saputra, Firandi; Maharani, Erika; Setianto, Budi Yuli